Chinook Therapeutics Probability of Future Stock Price Finishing Over 29.01
| KDNYDelisted Stock | USD 39.25 0.20 0.51% |
Chinook |
Chinook Therapeutics Target Price Odds to finish over 29.01
The tendency of Chinook Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above $ 29.01 in 90 days |
| 39.25 | 90 days | 29.01 | about 51.86 |
Based on a normal probability distribution, the odds of Chinook Therapeutics to stay above $ 29.01 in 90 days from now is about 51.86 (This Chinook Therapeutics probability density function shows the probability of Chinook Stock to fall within a particular range of prices over 90 days) . Probability of Chinook Therapeutics price to stay between $ 29.01 and its current price of $39.25 at the end of the 90-day period is about 39.89 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.45 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Chinook Therapeutics will likely underperform. Additionally Chinook Therapeutics has an alpha of 0.8861, implying that it can generate a 0.89 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Chinook Therapeutics Price Density |
| Price |
Predictive Modules for Chinook Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Chinook Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Chinook Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Chinook Therapeutics is not an exception. The market had few large corrections towards the Chinook Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Chinook Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Chinook Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.89 | |
β | Beta against Dow Jones | 1.45 | |
σ | Overall volatility | 8.37 | |
Ir | Information ratio | 0.12 |
Chinook Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Chinook Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Chinook Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Chinook Therapeutics is not yet fully synchronised with the market data | |
| Chinook Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 6.13 M. Net Loss for the year was (187.87 M) with loss before overhead, payroll, taxes, and interest of (135.08 M). | |
| Chinook Therapeutics currently holds about 362.61 M in cash with (117.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.76. | |
| Over 97.0% of the company shares are owned by institutional investors |
Chinook Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Chinook Stock often depends not only on the future outlook of the current and potential Chinook Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Chinook Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 64.4 M | |
| Cash And Short Term Investments | 378.3 M |
Chinook Therapeutics Technical Analysis
Chinook Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Chinook Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Chinook Therapeutics. In general, you should focus on analyzing Chinook Stock price patterns and their correlations with different microeconomic environments and drivers.
Chinook Therapeutics Predictive Forecast Models
Chinook Therapeutics' time-series forecasting models is one of many Chinook Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Chinook Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Chinook Therapeutics
Checking the ongoing alerts about Chinook Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Chinook Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Chinook Therapeutics is not yet fully synchronised with the market data | |
| Chinook Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 6.13 M. Net Loss for the year was (187.87 M) with loss before overhead, payroll, taxes, and interest of (135.08 M). | |
| Chinook Therapeutics currently holds about 362.61 M in cash with (117.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.76. | |
| Over 97.0% of the company shares are owned by institutional investors |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in Chinook Stock
If you are still planning to invest in Chinook Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Chinook Therapeutics' history and understand the potential risks before investing.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |